University of Texas/Texas AM Investment Management Co (UTIMCO)’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
|
|||||
2023
Q2 | $111K | Hold |
|
|||||
2023
Q1 | $71K | Hold |
|
|||||
2022
Q4 | $111K | Hold |
|
|||||
2022
Q3 | $129K | Hold |
|
|||||
2022
Q2 | $124K | Hold |
|
|||||
2022
Q1 | $565K | Hold |
|
|||||
2021
Q4 | $1.17M | Hold |
|
|||||
2021
Q3 | $1.95M | Sell |
|
|||||
2021
Q2 | $1.88M | Sell |
|
|||||
2021
Q1 | $2.21M | Hold |
|
|||||
2020
Q4 | $2.2M | Hold |
|
|||||
2020
Q3 | $1.98M | Hold |
|
|||||
2020
Q2 | $2.59M | Sell |
|
|||||
2020
Q1 | $1.5M | Hold |
|
|||||
2019
Q4 | $2.46M | Buy |
|
|||||
2019
Q2 | $2.3M | Hold |
|
|||||
2019
Q1 | $2.7M | Hold |
|
|||||
2018
Q4 | $2.51M | Hold |
|
|||||
2018
Q3 | $3.21M | Sell |
|
|||||
2018
Q2 | $3.6M | Sell |
|
|||||
2018
Q1 | $5.21M | Hold |
|
|||||
2017
Q4 | $2.84M | Hold |
|
|||||
2017
Q3 | $2.59M | Hold |
|
|||||
2017
Q2 | $2.02M | Hold |
|
|||||
2017
Q1 | $3.91M | Hold |
|
|||||
2016
Q4 | $2.28M | Hold |
|
|||||
2016
Q3 | $3.37M | Buy |
|